National HealthCare Corporation
NHCAMEXHealthcare● Active
$187.73
$-4.40(-2.29%)
Market Cap$2.9B
P/E Ratio—
52W High$205.06
52W Low$93.54
National HealthCare Corporation (NHC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NHC · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 8, 2026EPS Actual
$1.91
Revenue
$0.38B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 8, 2026
After Market Close
NHC reports quarterly as a AMEX-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | May 8, 2026 | — | $1.91 | — | $0.38B | — | — |
| — Q1 FY2026 | Feb 26, 2026 | — | $1.83 | — | $0.39B | — | — |
| — Q4 FY2025 | Nov 7, 2025 | — | $1.58 | — | $0.38B | — | — |
| — Q3 FY2025 | Aug 8, 2025 | — | $1.65 | — | $0.37B | — | — |
| — Q2 FY2025 | May 9, 2025 | — | $1.59 | — | $0.37B | — | — |
| — Q1 FY2025 | Feb 27, 2025 | — | $1.66 | — | $0.37B | — | — |
| — Q4 FY2024 | Nov 8, 2024 | — | $1.27 | — | $0.34B | — | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 8, 2026
EPS Actual
$1.91
EPS Est.
—
EPS Surpr.
—
Revenue
$0.38B
Q1 FY2026
Feb 26, 2026
EPS Actual
$1.83
EPS Est.
—
EPS Surpr.
—
Revenue
$0.39B
Q4 FY2025
Nov 7, 2025
EPS Actual
$1.58
EPS Est.
—
EPS Surpr.
—
Revenue
$0.38B
Q3 FY2025
Aug 8, 2025
EPS Actual
$1.65
EPS Est.
—
EPS Surpr.
—
Revenue
$0.37B
Q2 FY2025
May 9, 2025
EPS Actual
$1.59
EPS Est.
—
EPS Surpr.
—
Revenue
$0.37B
Q1 FY2025
Feb 27, 2025
EPS Actual
$1.66
EPS Est.
—
EPS Surpr.
—
Revenue
$0.37B
Q4 FY2024
Nov 8, 2024
EPS Actual
$1.27
EPS Est.
—
EPS Surpr.
—
Revenue
$0.34B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 9 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 9 |
| Q1 FY2023 | $1.43 | $1.43 | $1.43 | 9 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.4B | $0.4B | $0.4B | 11 |
| Q1 FY2024 | $0.4B | $0.6B | $0.7B | 18 |
| Q4 FY2023 | $0.4B | $0.5B | $0.6B | 17 |
| Q3 FY2023 | $0.5B | $0.6B | $0.7B | 19 |
| Q2 FY2023 | $0.5B | $0.6B | $0.7B | 18 |
| Q1 FY2023 | $0.4B | $0.5B | $0.6B | 12 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 8, 2026 | — | $171.42 | $188.82 | +10.15% |
| — Q1 FY2026 | Feb 26, 2026 | — | $160.33 | $160.17 | -0.10% |
| — Q4 FY2025 | Nov 7, 2025 | — | $125.00 | $127.17 | +1.74% |
| — Q3 FY2025 | Aug 8, 2025 | — | $96.41 | $100.38 | +4.12% |
| — Q2 FY2025 | May 9, 2025 | — | $94.66 | $100.54 | +6.21% |
| — Q1 FY2025 | Feb 27, 2025 | — | $92.60 | $93.33 | +0.79% |
| — Q4 FY2024 | Nov 8, 2024 | — | $129.92 | $134.43 | +3.47% |
| — Q3 FY2024 | Aug 9, 2024 | — | $121.24 | $122.88 | +1.35% |
Q2 FY2026+10.15%
Report Date
May 8, 2026
EPS Beat/Miss
—
Price Before
$171.42
Price After
$188.82
Q1 FY2026-0.10%
Report Date
Feb 26, 2026
EPS Beat/Miss
—
Price Before
$160.33
Price After
$160.17
Q4 FY2025+1.74%
Report Date
Nov 7, 2025
EPS Beat/Miss
—
Price Before
$125.00
Price After
$127.17
Q3 FY2025+4.12%
Report Date
Aug 8, 2025
EPS Beat/Miss
—
Price Before
$96.41
Price After
$100.38
Q2 FY2025+6.21%
Report Date
May 9, 2025
EPS Beat/Miss
—
Price Before
$94.66
Price After
$100.54
Q1 FY2025+0.79%
Report Date
Feb 27, 2025
EPS Beat/Miss
—
Price Before
$92.60
Price After
$93.33
Q4 FY2024+3.47%
Report Date
Nov 8, 2024
EPS Beat/Miss
—
Price Before
$129.92
Price After
$134.43
Q3 FY2024+1.35%
Report Date
Aug 9, 2024
EPS Beat/Miss
—
Price Before
$121.24
Price After
$122.88
Beat Rate0 / 8 quarters
Largest Move+10.15% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NHC ends December
National HealthCare Corporation (NHC) most recently reported earnings on May 8, 2026 for Q2 FY2026, posting EPS of $1.91 (in line with the analyst consensus of —).
Each quarter, investors track NHC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NHC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NHC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NHC earnings · 4 questionsNational HealthCare Corporation's next earnings report is expected around TBD. NHC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NHC historically reports after market close (AMC).
NHC earnings datewhen is NHC earningsNHC next earnings datewhen does NHC report earningsNHC earnings calendar
▸ Source: FMP · National HealthCare Corporation SEC filings · US GAAP · National HealthCare Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026